CV Risk Assessment Tool

Clinical Decision Support — Does Not Replace Clinical Judgment

About This Tool

Who it's for: Nurse practitioners and physicians.

What it's based on: The 2018 ACC/AHA Cholesterol Guideline (risk enhancers), ATP III criteria (metabolic syndrome), and the AHA PREVENT equations as recommended by the 2026 Dyslipidemia Guideline for formal risk estimation.

How to use it: Enter the patient's data to generate a cardiovascular risk assessment and a referral-routing recommendation — NP-level management, physician or PCP, or cardiology — with the appropriate urgency.

Developed by Amy Killen, MD · July 2026

1 Patient Information

Age

Sex

Race/Ethnicity

BMI (kg/m²)

Waist Circumference (inches) optional

3 Lab Values

Total Cholesterol (mg/dL)

LDL-C (mg/dL) <100 / 100-159 / ≥160

HDL-C (mg/dL) <40M/50F / 40-59 / ≥60

Triglycerides (mg/dL) <150 / 150-199 / ≥200

ApoB (mg/dL) <90 / 90-129 / ≥130

Lp(a) (mg/dL) <30 / 30-49 / ≥50

hsCRP (mg/L) <1.0 / 1.0-1.9 / ≥2.0

Fasting Insulin (uIU/mL) <8 / 8-12 / >12

A1c (%) <5.7 / 5.7-6.4 / ≥6.5

Homocysteine (umol/L) <10 / 10-15 / ≥15

Uric Acid (mg/dL) <6 / 6-7 / >7

Fasting Glucose (mg/dL) <100 / 100-125 / ≥126

eGFR (mL/min) ≥60 / 30-59 / <30

4 Imaging & Fitness

CIMT Percentile (from Vasolabs report)

Vascular Age (from Vasolabs report)

Plaque Present?

Plaque Type (if present)

Stenosis > 20%? (from Vasolabs report)

CIMT Notes (Vasolabs inconsistencies, prior results, etc.)

VO2 Max (mL/kg/min)

A Risk Enhancers

B Estimated ASCVD Risk Category

Formal risk should be calculated with the AHA PREVENT equations (10- and 30-year total CVD, ages 30–79) at professional.heart.org/en/guidelines-and-statements/prevent-calculator — the standard recommended by the 2026 Dyslipidemia Guideline, replacing the older Pooled Cohort Equations. This tool provides a category estimate based on risk-factor burden, not a formal percent.

C Decision & Routing

D Specific Recommendations

E Scope & Referral Summary